Azienda Ospedaliera Pugliese-Ciaccio
Catanzaro 88100
1 studies enrolling now · 5 studies all time
What they study most
Acquired Hemophilia A, Chronic Lymphocytic Leukemia, Lymphoma, T-Cell, Peripheral, Severe Hemophilia A, Small Lymphocytic Lymphoma
Studies at this site
- Nuwiq for Perioperative Management Of Patients With Haemophilia A on Emicizumab Regular Prophylaxis Study — Recruiting now
- Study of LOXO-305 (Pirtobrutinib) Versus Investigator's Choice (Idelalisib Plus Rituximab or Bendamustine Plus Rituximab) in Patients With Previously Treated Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) — Running, not enrolling
- A Trial of Pirtobrutinib (LOXO-305) Plus Venetoclax and Rituximab (PVR) Versus Venetoclax and Rituximab (VR) in Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) — Running, not enrolling
- Prospective and Retrospective, Non-interventional Study to Evaluate the Safety and Effectiveness of Obizur in Real-life Practice — Completed
- T-Cell Project: Prospective Collection of Data in Patients With Peripheral T-Cell Lymphoma — Completed